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Abstract. 
 
Oligodendrocyte-specific protein (OSP)/
 
claudin-11 is a major component of central nervous
system myelin and forms tight junctions (TJs) within
 
myelin sheaths. TJs are essential for forming a paracellular
barrier and have been implicated in the regulation of
growth and differentiation via signal transduction path-
ways. We have identified an OSP/claudin-11–associated
protein (OAP)1, using a yeast two-hybrid screen. OAP-1
is a novel member of the tetraspanin superfamily, and it is
widely expressed in several cell types, including oligoden-
 
drocytes. OAP-1, OSP/claudin-11, and 
 
b
 
1 integrin form a
 
complex as indicated by coimmunoprecipitation and
confocal immunocytochemistry. Overexpression of OSP/
claudin-11 or OAP-1 induced proliferation in an oligo-
dendrocyte cell line. Anti–OAP-1, anti–OSP/claudin-11,
 
and anti–
 
b
 
1 integrin antibodies inhibited migration of
primary oligodendrocytes, and migration was impaired
in OSP/claudin-11–deficient primary oligodendrocytes.
 
These data suggest a role for OSP/claudin-11, OAP-1,
 
and 
 
b
 
1 integrin complex in regulating proliferation and
migration of oligodendrocytes, a process essential for
normal myelination and repair.
Key words: tight junctions • myelin • TM4SF • brain
• OAP-1
 
Introduction
 
Myelin is essential for the effective and rapid propagation
of action potentials and therefore, the functional integrity
of the nervous system. Membrane processes from oligo-
 
dendrocytes in the central nervous system (CNS)
 
1
 
 and
Schwann cells in the peripheral nervous system wrap
around axons in a tight spiral-like manner, increasing the
resistance to current perpendicular to the axons. Oligo-
dendrocytes arise from precursor cells located in ventral
regions of the neural tube during development of the CNS.
These precursor cells must proliferate, migrate throughout
the CNS, and differentiate in order to form mature myelin.
The molecular mechanisms modulating these events are
not completely understood but can be directed in culture
by several growth factors, including platelet-derived
growth factor and basic FGF (Levine and Dou, 1991). In
recent years, there has been considerable progress in the
 
identification of glial proteins involved in the elaboration and
maintenance of myelin. Myelin basic proteins (MBPs) and
proteolipid protein (PLP) make up nearly 80% of the total
myelin proteins in the CNS (for reviews see Campagnoni,
1988; Bronstein et al., 1997) with myelin–oligodendrocyte
protein (Gardinier et al., 1992), myelin–oligodendrocyte
basic protein (Holz et al., 1996), and myelin-associated
 
glycoprotein contributing as minor components (for review
see Campagnoni and Macklin, 1988).
 
Oligodendrocyte-specific protein (OSP) is a putative
four-transmembrane protein that is primarily expressed in
oligodendrocytes of the CNS and Sertoli cells of testes in
 
the adult mouse (Bronstein et al., 1996; Morita et al., 1999).
OSP is the third most abundant CNS myelin protein, con-
tributing 7% of the total myelin protein (Bronstein et al.,
1997), and was found recently to share sequence homology
with the claudin family of tight junction (TJ) proteins
(Morita et al., 1999). OSP forms TJs in cell culture and to
more accurately reflect its function, OSP was renamed
OSP/claudin-11 (Morita et al., 1999). Although classical
TJs have not been described in myelin, similar structures
have been reported (Dermietzel et al., 1980), and OSP/
claudin-11 localizes to these structures (Morita et al.,
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1999). OSP/claudin-11 appears to be necessary for the for-
mation of TJs as OSP/claudin-11–null mice lack intramem-
branous junctions in between Sertoli cells in testes and
within CNS myelin sheaths, leading to reproductive and
neurological deficiencies (Gow et al., 1999). Indeed, OSP/
claudin-11 knockout mice have slowed CNS conduction
velocities, suggesting that OSP/claudin-11–containing TJs
are necessary for normal axonal function (Gow et al.,
1999). It is not yet known if the expression of OSP/claudin-
11 alone is sufficient to establish the TJ molecular barrier
or regulate intramembrane diffusion of lipids.
Three types of integral membrane proteins that localize
to TJs in vivo have been described: occludin (Furuse et al.,
1993), claudins (Furuse et al., 1998), and junction adhesion
membrane protein (Martin-Padura et al., 1998). It is likely
that these proteins are involved in establishing the barrier
function of TJs, although OSP/claudin-11 is the only pro-
tein to date to be found essential for the formation of
some intramembrane strands (Gow et al., 1999). Several
other proteins have been identified which localize to the
cytoplasmic membrane region of TJs: ZO-1 (Stevenson et
al., 1986), ZO-2 (Jesaitis and Goodenough, 1994), ZO-3
(Haskins et al., 1998), cingulin (Citi et al., 1988), 7H6
(Zhong et al., 1993), symplekin (Keon et al., 1996), AF-6/
afadin (Yamamoto et al., 1997), and some Rab proteins
(Weber et al., 1994; Zahraoui et al., 1994). These proteins
may mediate other proposed functions of TJ proteins such
as regulating cell growth, transformation, and differentia-
tion (Willott et al., 1993; Li and Mrsny, 2000; Reichert et
al., 2000; Ryeom et al., 2000). It has been proposed that
the cytoplasmic proteins associate with one or more of the
integral TJ membrane proteins, although direct evidence
is lacking. ZO-1 can associate with occludin in vitro (Fu-
ruse et al., 1994), although it continues to localize to TJs in
the occludin-deficient stem cells (Saitou et al., 1998) and in
the testes of the OSP/claudin-11 gene knockout mice
(Gow et al., 1999). A recent report has demonstrated di-
rect binding of ZO-1, ZO-2, and ZO-3 with the COOH
termini of claudins 1–8 in vitro (Itoh et al., 1999). This in-
teraction appears to be dependent on the PDZ domains of
ZO-1, 2, and, 3 and a COOH-terminal YV amino acid se-
quence of many of the claudins (Itoh et al., 1999). Unlike
other claudins, OSP/claudin-11 terminates with HV, and
no proteins have been identified to associate with it.
Since known TJ proteins apparently do not associate
with OSP/claudin-11, we have used the yeast two-hybrid
system to identify associated proteins. A novel member of
the tetraspanin super family (TM4SF) was isolated, which
interacted with the COOH termini of OSP/claudin-11. The
putative interaction was examined by coimmunoprecipita-
tion and by immunohistochemistry colocalization. We
have named this protein OSP/claudin-11–associated pro-
tein 1 (OAP-1). OAP-1 forms a complex with OSP/clau-
din-11 and 
 
b
 
1 integrin, and evidence is provided to sup-
port the role for this complex in regulating proliferation
and migration of oligodendrocytes.
 
Materials and Methods
 
Yeast Two-Hybrid Bait and Library Constructions
 
Three OSP/claudin-11 constructs were used as bait for yeast two-hybrid
screen: the entire OSP/claudin-11 ORF, the first extracellular domain of
 
OSP/claudin-11 between 35 and 84 amino acids, and the COOH terminus
of OSP/claudin-11 between 122 and 207 amino acids. These cDNAs were
cloned into the pGBT9 backbone (Matchmaker system; CLONTECH
Laboratories, Inc.). GAL4 activation domain cDNA fusion libraries were
constructed in modified pGAD GH vector (CLONTECH, Laboratories,
Inc.) using mRNA from mouse brain. Plasmids were transfected into
JM101-competent bacterial cells and amplified once on agar plates.
 
Yeast Two-Hybrid Screening
 
100 
 
m
 
g of library DNA and OSP/claudin-11 bait were cotransformed into
HF7c-competent yeast cells. Transformation of 
 
Saccharomyces cerevisiae
 
was performed using the lithium acetate method (Gietz et al., 1992). Two
reporter genes for interacting proteins are contained in the Hfc7 strain:
HIS3 and 
 
b
 
-galactosidase. Transformants which expressed interacting
proteins grew on histidine-dependent medium (His
 
2
 
); all positive clones
were transferred to sterile Whatman no. 5 filters, placed on selection
Trp
 
2
 
/ Leu
 
2
 
/His
 
2 
 
minimal synthetic dropout (SD) medium agar, incubated
for 1–3 d at 30
 
8
 
C, and fixed by freezing in liquid nitrogen. Filters were
then placed onto filter paper presoaked in buffer Z (100 mM NaH
 
2
 
PO
 
4
 
,
pH 7.0, 10 mM KCl, 1 mM MgSO
 
4
 
), supplemented with 50 mM 
 
b
 
-mercap-
toethanol and 0.07 mg/ml 5-bromo-4-chloro-3-indolyl-
 
b
 
-
 
D
 
-galactopyrano-
side (ONPG) (Sigma-Aldrich). Filters were then incubated at 30
 
8
 
C and
monitored for the appearance of blue colonies.
Plasmids from positive yeast colonies were isolated by Yeastmaker (a
yeast plasmid isolation kit) (CLONTECH Laboratories, Inc.) method. In
brief, yeast cells were spread onto His
 
2
 
/Leu
 
2
 
/Trp
 
2
 
 SD plates and incu-
bated at 30
 
8
 
C for 3–4 d. 10-mm
 
2
 
 portions of the yeast patch were scraped
and resuspended in Lyticase containing Tris-EDTA solution at 37
 
8
 
C for 60
min to destroy yeast cell walls, followed by the addition of 20% SDS, vor-
texed, and loaded onto Chroma spin-1000 columns. Columns were centri-
fuged at 700 
 
g
 
, and elutes containing plasmids were collected and stored at
 
2
 
20
 
8
 
C. Plasmids isolated from positive colonies were individually cotrans-
formed with OSP/claudin-11 bait cDNA and plated on His
 
2
 
 SD medium
and tested for 
 
b
 
-galactosidase activity as described above. Further confir-
mation of positive clones was also performed in SFY526 cells using a liquid
 
b
 
-galactosidase assay, using ONPG as substrate. For this assay, SFY526
yeast cells were transformed with candidate and bait plasmids, grown
overnight in Leu
 
2
 
/Trp
 
2
 
 SD medium mixed with YPD medium (CLON-
TECH Laboratories, Inc.), centrifuged, resuspended in buffer Z, and fro-
zen in liquid nitrogen, followed by an incubation with 0.07% ONPG for
2–5 h. Optical densities were measured at wavelengths of 420 and 600 nm.
Several controls were used to elucidate false positives. Positive controls
included cotransformation of pVA3-murine p53
 
(72
 
2
 
390)
 
 in pGBT9, with
pTD1-SV40 large T-antigen
 
(84
 
2
 
708)
 
 in pGAD3F and transformation of
pCL1 (wild-type full-length GAL4) (Fields and Song, 1989; Chien et al.,
1991). Negative controls included cotransformation of candidate clones
with pGAD GH library cloning vector, murine MBP in pGAD GH, and
pTD1 clone. Cotransformants were assayed for their ability to grow on
His
 
2
 
 medium and for 
 
b
 
-galactosidase activity.
 
Northern Blot Analysis
 
Total RNA was prepared from different mouse tissues as described by
Chomczynski and Sacchi (1987). Total RNA (10 
 
m
 
g/lane) was separated
electrophoretically on 1% agarose-formaldehyde gels, transferred to Hy-
bond™-N
 
1
 
 nylon membranes, and irreversibly fixed by incubating filters
at 80
 
8
 
C for 2 h. Prehybridization and hybridization were performed at
65
 
8
 
C in solutions containing 7.5% SDS, 0.5 M phosphate buffer, pH 7.0, 1
mM EDTA, and 1% bovine serum albumin. 
 
32
 
P-labeled ORF OAP-1
cDNA probes were generated by isolating cDNA from plasmid DNA and
using random primers according to the manufacturer’s protocol (New En-
gland Biolabs, Inc.). After hybridization, membranes were washed with
0.2
 
3
 
 SSC and 0.1% SDS at 61
 
8
 
C before exposure to x-ray film. Northern
blots were normalized with radiolabeled 18S probe (Ambion).
 
In Situ Hybridization
 
In situ hybridization was performed on adult mouse brains as described
previously (Kornblum et al., 1994). In brief, an adult mouse was perfused
fixed before sectioning of the brain. The probes used for localization stud-
ies were obtained by in vitro transcription in the presence of [
 
35
 
S]UTP
from linearized pGEM 7Zf plasmids containing mouse OAP-1 cDNA.
Hybridization was carried out at 60
 
8
 
C overnight in a mixture containing
50% formaldehyde, 10% dextran sulfate, 0.7% ficoll, 0.7% polyvinyl pyr-
rolidone, 0.7% BSA, 0.15 mg/ml yeast transfer RNA, 0.33 mg/ml dena-
tured salmon sperm DNA, 40-mM DTT, and 
 
35
 
S-labeled cRNA at a con-
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centration of 10
 
7
 
 cpm/ml of hybridization solution. After hybridization,
hydrolysis of nonspecifically hybridized probe was initiated by treatment
of brain sections with 30 
 
m
 
g/ml ribonuclease A in 10 mM Tris saline with 1
mM EDTA for 40 min at 45
 
8
 
C. Subsequently, the sections were rinsed
through descending concentrations of SSC buffer containing 100 mM so-
dium thiosulfate. The distribution of hybridization was localized by an ex-
posure to Beta Max film (Amersham Pharmacia Biotech) and Eastman
Kodak Co. NTB2 emulsion. Films were exposed for 2–4 d and subjected
to liquid emulsion for 2–8 wk. Tissue sections were counterstained with
hematoxylin and eosin after autoradiographic development.
 
Cell Culture
 
Cell Line. 
 
A conditionally immortalized mouse oligodendrocyte cell line
(CIMO) (Bronstein et al., 1998) was grown in DME/HAM F12 supple-
mented with 5% FCS, transferrin, selenium (Reduser; Upstate Biotech-
nology), and gamma interferon (I
 
g
 
; 100 U/ml) (GIBCO BRL) at 33
 
8
 
C or
37
 
8
 
C in 5% CO
 
2
 
. Cells were either maintained in medium with I
 
g
 
 at 33
 
8
 
C
(permissive) or 37
 
8
 
C in medium lacking I
 
g
 
 (nonpermissive). CIMO cells
were stable-transfected with pBabe vector, OSP/claudin-11, antisense
OSP/claudin-11, PLP, and MBP in pBabe vector separately and
pcDNA3.1 vector alone and OAP-1 in pcDNA3.1 vector. DOTAP liposo-
mal transfection reagent (Boehringer) was used for transfection according
to the manufacturer’s protocol. Stable transformants were maintained af-
ter antibiotic (neomycin 400 
 
m
 
g/ml for pBabe vector background and
genetecin 500 
 
m
 
g/ml for pcDNA vector background) selection.
 
Purification of Oligodendrocytes. 
 
Purified oligodendrocytes were ob-
tained using a technique modified from McCarthy and de Vellis (1980). In
brief, primary cultures were established from rat and mice (wild-type,
OSP/claudin-11 homozygous, and heterozygote knockout) neonatal fore-
brain cells obtained by dissociating cerebral cortices in papain and grown
for 
 
z
 
10 d in DME/F12 supplemented with 10% heat-inactivated FCS. The
flasks were shaken overnight to separate the loosely attached oligoden-
drocyte precursors. These cells were centrifuged and resuspended in ap-
propriate medium and used for immunocytochemistry and cell migration
assays (Milner et al., 1996).
 
Antibodies
 
Anti–OSP/claudin-11 antibody was made as described previously (Bron-
stein et al., 1997). Rabbit polyclonal antibodies for OAP-1 were raised
against an 18–amino acid peptide (H-YSDWENTDWFKETKNQSV-
OH) conjugated to keyhole limpet hemocyanin (Research Genetics). The
18 amino acids (153–170) (see Fig. 1) correspond to a region within the
putative second extracellular loop of OAP-1. Antibody specificity was
confirmed by Western blot, immunohistochemistry, and peptide competi-
tion experiments. Anti-GFAP antibody, peroxidase-conjugated, and
horseradish-conjugated goat anti–rabbit antibody were purchased from
Zymed Laboratories. Anti–
 
b
 
1 integrin antibody (Chemicon), Texas red–
labeled and FITC-labeled goat anti–rabbit antibody, FITC-labeled goat
anti–mouse antibody (Vector Laboratories), and anti-GalC antibody
(Boehringer) were used in different concentrations for immunohis-
tochemistry and in some cases for Western blots and migration assays.
 
Immunohistochemistry and Confocal Microscopy
 
Oligodendrocytes were grown on Lab-Tek chamber slides for 4–8 d. For
experiments in fixed cells, cultures were washed with PBS, fixed with 4%
paraformaldehyde for 20 min at 4
 
8
 
C, and treated with 0.3% TX-100 in PBS
plus 2% normal goat serum for 10 min at room temperature either before
or after incubation of cells with primary antibodies. Some cells were also
treated with 100% ice-cold methanol for 10 min at 
 
2
 
20
 
8
 
C. Both live and
fixed cells were blocked for 2 h in 25% normal goat serum in TBS; primary
antibody was either added for 2 h at room temperature or overnight at
4
 
8
 
C. Antibody dilutions were as follows: OSP/claudin-11, 1:50; OAP-1,
1:250; and 
 
b
 
1 integrin, 1:50. Antigen–antibody interactions were visualized
with anti–rabbit IgG conjugated to Texas red (1:3,000) and FITC (1:2,000)
and anti–mouse IgG conjugated to FITC (1:1,000). Live cells were then
fixed with 4% paraformaldehyde. After staining, slide chambers were re-
moved, and slides were coverslipped with Fluoromount (Fisher Scientific).
Cells were examined with a ZEISS LSM 410 laser confocal microscope
system. The excitation source was a krypton argon laser (Coherent) with
output at 488, 568, and 633 nm. Fluorescein fluorescence was imaged with
a 488-nm emission filter and a 515–540-nm band pass filter. Texas red flu-
orescence was imaged with a 568-nm emission filter. The resulting images
were created by projecting several optical sections obtained at different
1-
 
m
 
m intervals through the cells in the z-axis.
 
Immunogold Electron Microscopy
 
Primary oligodendrocytes were grown in filter chambers (Corning) for 3 d
before washing them three times with PBS. The cells were fixed in 1%
glutaraldehyde and 2% paraformaldehyde for 20 min at room tempera-
ture. They were permeabilized and blocked in a similar manner used for
confocal immunocytochemistry. OSP/claudin-11 and OAP-1 antibodies
were used at 1:50 concentration. The cells were washed and incubated
with anti–rabbit IgG conjugated to 12-nm colloidal gold particles (Jackson
ImmunoResearch Laboratories) for 1 h at room temperature. They were
washed and processed by standard methods, and ultrathin cryosectioning
was performed as described previously (Bronstein et al., 2000).
 
Cell Surface Biotinylation
 
Cell surface proteins of primary oligodendrocytes were biotinylated by us-
ing a method modified from Mody et al. (1999). In brief, primary oligo-
dendrocyte monolayers were washed and then incubated for 30 min at
room temperature in the presence of 1 mM sulfosuccinimydyl-6 (biotina-
mido)-hexanoate (Sulpho-NHS-Biotin; Pierce Chemical Co.) in PBS. For
immunoprecipitation, flasks were washed with PBS and 0.5 M Tris-Cl, and
cells were solubilized in buffer A with 1% Triton X-100. Cells were solubi-
lized after washing with PBS and 0.5 M Tris-Cl, centrifuged, and Strepavi-
din-agarose beads (Sigma-Aldrich) were added to the supernatant. After
3 h of incubation, beads were collected by brief centrifugation and
washed. Immunoprecipitated protein was dissociated from the beads by
addition of SDS-containing sample buffer with 
 
b
 
-mercaptoethanol and
DTT and heating for 4 min. The sample was subjected through 12% SDS-
PAGE, and electroblotted protein was probed with anti–OSP/claudin-11
and anti–OAP-1 antibodies.
 
Immunoprecipitation and Western Blot Analysis
 
Primary oligodendrocytes, CIMO cells, and biotinylated primary oligo-
dendrocytes grown to confluence were washed with 1
 
3
 
 PBS. Primary cells
and mouse brain homogenates were homogenized in PBS, 0.6 mM PMSF,
1.5 mM EDTA, 0.003% leupeptin, and 0.6 mM DTT. The brain and cell
homogenates were subsequently resuspended in buffer A (20 mM Tris-
HCl, pH 7.6, 150 mM NaCl, 1% Triton X-100) for 30 min on ice. Insoluble
material was pelleted by centrifugation at 18,000 
 
g
 
 for 10 min at 4
 
8
 
C. Cel-
lular lysate was precleared with 40 
 
m
 
l of protein A (Sepharose/agarose)
beads for 1 h at 4
 
8
 
C and centrifuged at 3,000 
 
g
 
 for 10 min. Specific mole-
cules were immunoprecipitated by the incubation of 120-
 
m
 
g protein super-
natant with purified primary antibody overnight at 4
 
8
 
C, followed by incu-
bation with protein A beads for 1 h at 4
 
8
 
C. The beads were washed three
times for 15 min with cold buffer A and resuspended in SDS-PAGE load-
ing buffer. 30 
 
m
 
g of cell homogenate per lane was subjected to SDS-
PAGE on 12% (wt/vol) acrylamide gels (Laemmli, 1970). Proteins were
transferred to nitrocellulose membranes by semidry electroblotting. Blots
were blocked in 5% BSA in TBS-T (20 mM Tris-HCl, pH 7.5, 150 mM
NaCl, 0.1% Tween 20 [vol/vol]) and then probed with primary antibodies
for either 2 h at room temperature or overnight at 4
 
8
 
C. The blots were
washed with TBS-T and probed with HRP-conjugated secondary anti-
body. Chemiluminescence substrate (Pierce Chemical Co.) was used for
the HRP reaction.
 
Proliferation Assays
 
To evaluate the effect of OSP/claudin-11 and OAP-1 overexpression on
proliferation, [
 
3
 
H]thymidine incorporation was measured in CIMO cells
stably transfected with either pcDNA3.1 vector alone, pcDNA3.1-contain-
ing OAP-1, pBabe vector alone, or pBabe-containing OSP/claudin-11, an-
tisense OSP/claudin-11, PLP, and MBP. Overexpression of OSP/claudin-
11, OAP-1, and controls was confirmed by Northern and Western blot
analysis. Cells were incubated with [
 
3
 
H]thymidine (0.2 mCi/well) for 16 h
under permissive or nonpermissive conditions, washed, and DNA was pre-
cipitated with 5% TCA and subsequently determined by a liquid scintilla-
tion counter. Incorporated radioactivity was measured in triplicates. All
experiments were performed in triplicates and done at least four times.
 
Cell Migration Assay
 
Cell migration was quantified by measuring the number of cells migrating
from the agarose drops using a modification of the method described by
Varani et al. (1978). Oligodendrocytes were resuspended at 4 
 
3
 
 10
 
7
 
 cells/
ml in Sato medium containing 10% heat-inactivated FCS and 0.3% low
melting agarose maintained at 37
 
8
 
C to prevent setting of the agarose.
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Drops of the cell suspension (2 
 
m
 
l) were applied to the center of wells in a
24-well tissue culture dish, which were then placed at 4
 
8
 
C for 20 min to al-
low the agarose to solidify. The drops were then covered with 50 
 
m
 
l of
Sato medium containing 10 
 
m
 
g/ml fibronectin (Sigma-Aldrich) and incu-
bated for 30 min at 37
 
8
 
C. An additional 350 
 
m
 
l of Sato medium containing
platelet-derived growth factor (5 ng/ml) and fibronectin was added to all
of the wells with and without antibodies. Cell migration was measured at
daily intervals for 1–4 d. At least three experiments were performed and
within a single experiment, each condition was tested in four different
wells. Statistical significance was assessed by using the Student’s paired 
 
t
 
test in which
 
 P 
 
,
 
 0.05 was considered statistically significant.
 
Results
 
A Novel Protein Interacts with the COOH Terminus 
of OSP/Claudin-11
 
A mouse brain cDNA GAL4 activation domain library
was screened with three different OSP/claudin-11 GAL4-
binding domain baits in pGBT vector: the entire OSP/
claudin-11 ORF, extracellular loop of OSP/claudin-11 be-
tween 35 and 84 amino acids, and COOH terminus of
OSP/claudin-11 between 122 and 207 amino acids. Only
 
transfection with OSP/claudin-11 COOH terminus bait re-
sulted in positive colonies. Of 2 
 
3
 
 10
 
6
 
 transformants
screened, 140 colonies grew on His
 
2
 
 selection medium;
two of these were 
 
b
 
-galactosidase positive. None of the
negative controls grew on His-deficient medium or acti-
vated lacZ transcription. OSP/claudin-11 cotransformed
with OAP-1 activated the lacZ reporter in a manner simi-
lar to our positive controls of pVA3, pTD1 (murine p53
and SV40 large antigen), and pCL1.
 
OAP-1 Is a Member of the Tetraspanin Superfamily
 
OAP-1 cDNA (700 bp) was partially sequenced, and
BLAST search revealed that it is a novel clone. The com-
plete OAP-1 cDNA was then isolated from a spinal cord
cDNA library and composed of 1,679 bp with an ORF of
762 bp (sequence data available from GenBank/EMBL/
DDBJ under accession number AF242591). The predicted
protein has 254 amino acid residues and a calculated mo-
lecular mass of 28 kD. The original OAP-1 clone isolated
from the yeast two-hybrid screen contained nucleotide se-
quence 778–1053 of the ORF, corresponding to amino ac-
ids 162–254 (COOH termini). Sequence homology and hy-
dropathy plot analysis suggested that OAP-1 belongs to
the transmembrane 4 superfamily (TM4SF). TM4SFs in-
clude 
 
$
 
21 different proteins that have four transmem-
brane-spanning domains and exhibit high homology in 24
conserved regions that are specific for the TM4SF (Todd
et al., 1998). Alignment of the OAP-1 sequence with some
murine and human TM4SF members (mA15, mCD53,
Figure 1. OAP-1 belongs to the tetraspanin family of proteins. (A)
Multiple sequence alignment of OAP-1 with murine tetraspanins
(mA15, mCD53, mCD63, mCD82), a rat tetraspanin (rTspan-2),
and a human tetraspanin (hTspan-3). Boxed residues denote con-
servation among TM4SFs. (B) Kyte-Doolittle hydropathy plot
of the predicted amino acid sequence of OAP-1, predicting
four-transmembrane hydrophobic domains (arrows).
Figure 2. Presence of OAP-1 mRNA and protein in mouse
brain and oligodendrocytes. (A) Northern blot analysis of OAP-1
expression. mRNA isolated from normal spinal cord (lane 1),
brain (2), testes (3), skeletal muscle (4), heart (5), kidney (6),
spleen (7), and lung (8) was probed with a 32P-labeled 1.9-kB
cDNA of OAP-1. OAP-1 RNA was abundant in all tissue types.
Gel loading was quantified with 18S expression. (B) Northern
blot analysis of OAP-1 expression in mouse brain homogenate
(BH) and purified oligodendrocytes (OL) from mouse brain. (C)
Western blot analysis of OAP-1 protein in oligodendrocyte progeni-
tor cells (O2A), purified mouse oligodendrocytes, and mouse brain
homogenate. Preincubation of antibody with OAP-1–specific
peptide eliminated the 31-kD band confirming antibody specificity
(1Pep).
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mCD63, mCD82, mTspan-6, and hTspan-3) revealed
highly conserved amino acids specific for tetraspanins
(Fig. 1 A). There are four sites of potential NH2-linked
glycosylation in extracellular domain 2. For OAP-1 and
other TM4SF proteins, conserved sequences are primarily
within the putative transmembrane domains analyzed by a
Kyte-Doolittle plot (Fig. 1 B). In contrast, the extracellu-
lar domains are more divergent in terms of length, se-
quence, and degree of glycosylation. Sequence similarity
between murine OAP-1 and human tetraspanin Tspan-3
suggests that they are homologues.
OAP-1 mRNA Is Expressed in Oligodendrocytes
OAP-1 is widely expressed in brain and other tissues.
Northern blot analysis revealed a 1.9-kb mRNA present in
all the tissues tested, including spinal cord, brain, testes,
skeletal muscle, heart, kidney, spleen, and lung (Fig. 2 A).
A second band of z4 kb was also present in much lower
levels. This may represent an alternate transcript or an-
other gene product with high homology to OAP-1. North-
ern blot analysis on RNA from purified primary mouse
oligodendrocyte cultures and from the CIMO cell line
confirmed the presence of OAP-1 expression in oligoden-
drocytes (Fig. 2 B and see Fig. 7 A). Western blot analysis
revealed a single band of z31 kD in O2A oligodendrocyte
progenitor cells (Fig. 2 C). Two bands of z31 and 60 kD
were present in mature oligodendrocytes and mouse brain
homogenates, although under strong reducing conditions
(20% b-mercaptoethanol and 50 mM DTT) only the 31-
kD band was apparent. The band was eliminated by prein-
cubation of the OAP-1 antibody with peptide (Fig. 2 C).
These data suggest that the antibody specifically recog-
nized OAP-1 protein and that the 60-kD band was a dimer
of OAP-1 protein.
Using in situ hybridization, we found that OAP-1
mRNA was expressed in all areas of the mouse brain with
high levels in hippocampal pyramidal neurons and moder-
ate levels in oligodendrocytes of the corpus callosum (Fig.
3, A and B). Unlike OSP/claudin-11 staining in myelin
tracts (Fig. 3 C), immunohistochemistry demonstrated
that OAP-1 expression was more widespread, consistent
with in situ hybridization experiments (Fig. 3 D).
OSP/Claudin-11, OAP-1, and b1 Integrin Form 
a Complex
To determine if the association of OSP/claudin-11 with
OAP-1 occurs in vivo, we performed immunoprecipita-
tion. Homogenates were precipitated under relatively
stringent conditions (1% Triton X-100) with either anti–
OSP/claudin-11 or anti–OAP-1 antibodies. Western blots
of the precipitated proteins confirmed OSP/claudin-11–
OAP-1 association in both mouse brain (Fig. 4 A) and pri-
mary oligodendrocyte homogenates (Fig. 4 B).
Most if not all TM4SFs (for example, CD81, CD9, CD53,
CD63, and CD82) are known to associate with a vast range
of integrins in various types of cells (for review see Maecker
et al., 1997). This is also true for OAP-1, since it was immu-
noprecipitated with anti–b1 integrin (Fig. 4, A and B). The
Figure 3. In situ hybridization and im-
munohistochemistry showing OAP-1
expression in mouse forebrain. (A)
Dark field photomicrograph of adult
rat forebrain after in situ hybridization
using 35S–OAP-1 cRNA shows dense
neuronal expression of OAP-1 mRNAs
in the CA1 region of a P10 mouse
hippocampus. The area under the
square is shown in B. (B) A high
power bright field photomicrograph
showing expression of OAP-1
mRNA in oligodendrocytes of the
corpus callosum (arrowheads). (C)
Using an immunohistochemistry anti–
OSP/claudin-11 antibody (Texas red
secondary antibody) showed staining
primarily in white matter tracts and not
in pyramidal cells and astrocytes (large
arrow). Small arrows denote the outer
borders of corpus callosum. (D) In
contrast to OSP/claudin-11, immuno-
histochemistry using anti–OAP-1 anti-
body (FITC secondary antibody) in the
same section demonstrated widespread
staining in white matter tracts and in
areas containing pyramidal cells and
astrocytes (large arrow).
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complementary experiments indicated that OSP/claudin-11
(Fig. 4 C) and b1 integrin (Fig. 4 D) can be immunoprecipi-
tated from mouse brain homogenates with anti–OAP-1.
Furthermore, OSP/claudin-11 and OAP-1 were immuno-
precipitated with anti–b1 integrin antibody, and b1 integrin
was immunoprecipitated with anti–OSP/claudin-11 anti-
body (Fig. 4). The identity of b1 integrin on the Western
blots was confirmed using both polyclonal and monoclonal
antibodies. OSP/claudin-11, OAP-1, and b1 integrin also
coimmunoprecipitated in CIMO cell line under permissive
and nonpermissive conditions (Fig. 4 E). Neither b1 inte-
grin, OAP-1, nor OSP/claudin-11 was precipitated when the
primary antibody was omitted or when an unrelated anti-
body GFAP was used as the primary antibody. Silver stain-
ing of OSP/claudin-11, OAP-1, and b1 integrin immunopre-
cipitated mouse brain homogenates showed two to four
bands corresponding to the molecular masses of OSP/clau-
din-11, OAP-1, and b1 integrin along with the IgG band at
z50 kD (Fig. 4 F). These results suggest that OAP-1, OSP/
claudin-11, and b1 integrin form a complex in the brain and
oligodendrocyte homogenates.
Additional confirmation of an association between
OSP/claudin-11, OAP-1, and b1 integrin was obtained us-
ing double-labeled immunocytochemistry and confocal
microscopy (Fig. 5 A). Controls with GFAP showed no
colocalization with any of the experimental proteins (data
not shown). A striking colocalization of OSP/claudin-11,
OAP-1, and b1 integrin was observed in most oligoden-
drocytes (Fig. 5 A, third panel in rows 1 and 2). A few oli-
godendrocytes showed only partial colocalization (data
not shown), suggesting that complex formation was under
dynamic control or that the population of oligodendro-
cytes was heterogeneous.
OSP/Claudin-11, OAP-1, and b1 Integrin Is a Surface 
Membrane Protein Complex
We predicted that both OSP/claudin-11 and OAP-1 are
membrane bound based on their high level of hydropho-
bicity and known subcellular localization of b1 integrin.
Consistent with our hypothesis, OAP-1 and OSP/claudin-
11 colocalized on the cell surface of nonpermeabilized live
oligodendrocytes immunolabeled before fixation (Fig. 5
B). Surface labeling with anti-OSP antibody was absent in
OSP-null oligodendrocytes (data not shown). Further-
more, surface protein biotinylation of nonpermeabilized
oligodendrocytes resulted in biotinylation of OSP/claudin-
11 and OAP-1 (Fig. 6, A and B). To determine if OSP/
claudin-11 and OAP-1 complex on the surface of cells, oli-
godendrocytes from wild-type (1/1) and OSP/claudin-11
knockout (2/2) mice were biotinylated and subjected to
coimmunoprecipitation. OSP/claudin-11 and OAP-1 pro-
tein were detected in OSP/claudin-11 and OAP-1 1/1 im-
munoprecipitated biotinylated oligodendrocytes (Fig. 6, C
and D). Neither OSP/claudin-11 or OAP-1 protein was de-
tected in 2/2 oligodendrocytes immunoprecipitated with
anti–OSP/claudin-11, although OAP-1 was detected in
OAP-1 immunoprecipitated 2/2 oligodendrocytes (Fig. 6,
C and D). Surface localization of these proteins was also
confirmed using immunohistochemical EM. Immunoreac-
tive protein localized primarily to the outer cell mem-
branes of primary oligodendrocytes and appeared to be
more concentrated on their processes (Fig. 6 E).
Overexpression of OSP/Claudin-11 and OAP-1 
Increases Proliferation in CIMO Cells 
TM4SFs and TJs have been implicated in the regulation of
cellular proliferation. To study the effect of altered OAP-1
and/or OSP/claudin-11 gene expression on growth, CIMO
cells were used (Bronstein et al., 1998). Under permissive
conditions (338C 1 Ig), CIMO cells grew rapidly and were
relatively undifferentiated. When transferred to nonper-
missive conditions (378C, lacking Ig), the cells had a more
differentiated morphology, grew slowly, and expressed
myelin proteins. OSP/claudin-11 mRNA levels were 11-
fold higher and OAP-1 levels were 1.5-fold higher in
CIMO cells grown under permissive (Fig. 7 A) compared
with nonpermissive conditions (Fig. 7 A). Increased
mRNA expression could have reflected a response to
higher cell proliferative rate or may have helped induce
proliferation. To distinguish between these possibilities,
CIMO cells were transfected with various constructs to al-
ter gene expression, and their effect on proliferation was
Figure 4. OAP-1 associates with OSP/claudin-11 and b1 integrin.
(A) Mouse brain homogenates were immunoprecipitated with
anti-OSP, anti–OAP-1, anti-GFAP, or anti–b1 integrin and then
probed with anti–OAP-1 antibody. (B) Primary oligodendrocyte
homogenates were immunoprecipitated with anti-OSP, anti–
OAP-1, anti-GFAP, or anti–b1 integrin and then probed with
anti–OAP-1 antibody. (C) Mouse brain homogenates were im-
munoprecipitated with anti-OSP, anti–OAP-1, anti-GFAP, or
anti–b1 integrin and then probed with anti–OSP/claudin-11 anti-
body. (D) Mouse brain homogenates were immunoprecipitated
with anti-OSP, anti-OAP-1, anti-GFAP, or anti–b1 integrin and
then probed with anti–b1 integrin antibody. (E) CIMO homoge-
nates were immunoprecipitated with anti-OSP, anti–b1 integrin, or
anti-GFAP and then probed with anti–OAP-1 antibody. (F) Sil-
ver-stained gel of anti–OSP/claudin-11 (lane 1), anti–OAP-1 (lane
2), and anti–b1 integrin (lane 3) immunoprecipitated mouse brain
homogenate. Small arrows denote bands that correspond to the
molecular masses of OAP-1, OSP/claudin-11, and b1 integrin. The
IgG band is visible at z50 kD.
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measured. CIMO cells overexpressing OSP/claudin-11
protein or OAP-1 protein were confirmed via Western
blot analysis (Fig. 7 B). Under permissive conditions, over-
expression of OSP/claudin-11 had no significant effect on
[3H]thymidine incorporation in CIMO cells nor did over-
expression of PLP, MBP, or OSP antisense (in an attempt
to lower endogenous OSP/claudin-11) (Fig. 7 C). When
the cells were transferred to nonpermissive conditions, the
cells overexpressing OSP/claudin-11 incorporated 81-fold
more [3H]thymidine compared with those transfected with
vector alone and took on a less differentiated appearance.
In fact, overexpression of OSP/claudin-11 under these
conditions had a 2.5-fold greater proliferative effect than
that of a known mitogen, SV40ts58 antigen. There was an
increase in cellularity and necessity to passage cells more
frequently, consistent with the concept that increase in
[3H]thymidine incorporation reflected an increase in pro-
liferation. Thus, OSP/claudin-11 had a powerful prolifera-
tive effect on differentiated CIMO cells but not on
less differentiated CIMO cells. Interestingly, OAP-1
overexpression of CIMO cells increased proliferation
greater than twofold compared with vector alone controls
Figure 5. OSP/claudin-11
colocalizes with OAP-1 and
b1 integrin in oligodendro-
cytes. (A) Confocal images of
primary mouse oligodendro-
cytes shown in the top row
were double labeled for
OSP/claudin-11 (Texas red)
and OAP-1 (FITC) or b1 in-
tegrin (FITC). Fused images
are shown at the far right and
bottom. Most cells showed
striking colocalization of OSP/
claudin-11, OAP-1, and b1 in-
tegrin. (B) Confocal images
of primary mouse oligoden-
drocytes shown were double
labeled for OAP-1 (Texas
Red) and OSP/claudin-11
(FITC) in live primary oligo-
dendrocytes. Fused images
are showed to the far right.
Colocalization of the two
proteins was mostly observed
in the cell borders. (C) Live
primary oligodendrocytes
were cultured on slides and
immunostained with anti–
OAP-1 (top row) and anti–
OSP/claudin-11 (bottom row)
antibody in the presence and
absence of the respective an-
tibody peptides. Background
staining is also shown. Bars:
(A, top row) 10 mM; (A, bot-
tom row) 25 mM.
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under both growth permissive and nonpermissive condi-
tions (Fig. 7 C).
OAP-1–OSP/Claudin-11–b1 Integrin Complex 
Regulates Oligodendrocyte Migration
Cell proliferation, differentiation, and migration are at
least partially mediated by the interaction between cell
membrane proteins and extracellular matrix (ECM). Inte-
grins are a key family of ECM receptors, and avb1 integrin
has been shown to play a role in oligodendrocyte migration
(Milner et al., 1996). Since OSP/claudin-11 and OAP-1
form a complex with b1 integrins, it is likely that they are
involved in cellular interactions with ECM. The possible
involvement of OSP/claudin-11 and OAP-1 in oligoden-
drocyte migration was tested using an established in vitro
assay used previously to demonstrate that integrins are in-
volved in oligodendrocyte migration (Varani et al., 1978;
Milner et al., 1996). Primary oligodendrocytes were plated
in an agarose drop in the presence (positive control) or ab-
sence (negative control) of fibronectin. Maximal migration
in positive controls was achieved in 4 d, with 58 6 12 cells
per well appearing in the migratory zone. Migration of oli-
godendrocytes was inhibited significantly in the presence
of anti–OSP/claudin-11, anti–OAP-1, and anti–b1 integrin
antibodies by 95, 76, and 88% of the control, respectively
(Fig. 8 A). The inhibitory effect of the antibodies on migra-
tion was specific, since inactive anti–OAP-1 (boiled for 10
min) and anti-GFAP (unrelated) antibody had no effect.
Reduced migration also did not reflect decreased viability
since .95% of all cells under all conditions remained via-
ble as determined by trypan blue staining.
We were surprised by the significant inhibition of migra-
tion in the presence of anti–OSP/claudin-11 antibody, since
the recognizable epitope is predicted to be intracellular. To
confirm that the anti–OSP/claudin-11 antibody was indeed
recognizing protein epitopes on live oligodendrocytes, cul-
tures were incubated with anti–OSP/claudin-11 antibodies
and with antibody that had been preincubated with OSP/
claudin-11 peptide (Fig. 5, B and C). We observed specific
labeling of live cells, although not as pronounced as with
permeabilized oligodendrocytes (data not shown). This
staining was markedly attenuated by preincubation with
peptide and was absent in OSP-null oligodendrocytes,
demonstrating specificity of the antibody labeling.
Migration assays using oligodendrocytes isolated from
OSP/claudin-11–null mice add further support to OSP/
claudin-11’s role in migration. Oligodendrocytes com-
pletely lacking OSP/claudin-11 had markedly reduced
ability to migrate compared with wild-type cells, whereas
migration assays using heterozygote cells resulted in inter-
mediate values (Fig. 8 B). Interestingly, only fibronectin-
dependent migration was affected by alterations in OSP/
claudin-11 gene dosage.
Discussion
Although several proteins have been localized to TJs, none
have been shown to associate directly with OSP/claudin-11.
Reported here is the identification of an OSP/claudin-11–
interacting protein, OAP-1. It is evident from sequence
analysis that OAP-1 is a member of the TM4SF. OAP-1,
like other members of TM4SF, has (a) four highly con-
served hydrophobic transmembrane domains, (b) charged
residues in or near the transmembrane domains, and (c)
conserved cysteine residues in the second transmembrane
domain (Maecker et al., 1997). Tspan-1–Tspan-6 are also
new members of the TM4SF family, which were identified
by Todd et al. (1998) by searching the dbEST database.
OAP-1 shares highest homology with human Tspan-3 and is
likely the mouse homologue of human Tspan-3. Like hu-
man Tspan-3 mRNA expression, murine OAP-1 showed
widespread tissue expression. Within the CNS, OAP-1 lo-
calized to oligodendrocytes, neurons, and astrocytes.
Members of TM4SF have been implicated in several ba-
sic biological processes (Hemler et al., 1996; Maecker et al.,
Figure 6. OAP-1 and OSP/claudin-11 proteins are present on the cell surface.
(A) Cell surface proteins of oligodendrocytes were biotinylated using a mem-
brane-impermeant biotin ester. After solubilization and recovery of biotinylated
proteins using Strepavidin-agarose, OAP-1 (lane 2) and OSP/claudin-11 (lane 3)
proteins expressed at the plasma membrane were identified by SDS-PAGE and
immunoblotting. Nonbiotinylated proteins (lane 1) were not observed. (B)
Surface biotinylated oligodendrocyte proteins isolated from wild-type and OSP/claudin-11 transgenic mice were immunoprecipitated
with anti–OAP-1 antibody (1/1, lane 1) and anti–OSP/claudin-11 antibody (1/1, lane 2; 2/2, lane 3). Nonbiotinylated protein from
wild-type oligodendrocytes was precipitated with anti–OSP/claudin-11 antibody (lane 4). Biotinylated proteins were visualized using
Streptavidin-HRP as described in Materials and Methods. (C) Surface-biotinylated primary oligodendrocyte homogenates from wild-
type and OSP/claudin-11 transgenic mice were immunoprecipitated with anti–OAP-1 antibody (1/1, lane 1) or anti–OSP/claudin-11
antibody (1/1, lane 2; 2/2, lane 3) and probed with anti–OSP/claudin-11 antibody. (D) Surface-biotinylated primary oligodendrocyte
homogenates from wild-type and OSP/claudin-11 transgenic mice were immunoprecipitated with anti–OAP-1 antibody (1/1, lane 1) or
anti–OSP/claudin-11 antibody (1/1, lane 2; 2/2, lane 3) and probed with anti–OAP-1 antibody. (E) Immunohistochemical EM of
primary oligodendrocytes. OSP/claudin-11 and OAP-1 immunoreactivity was localized to the outer cell membrane (arrows). The asterisks
represent the filter matrix the oligodendrocytes were grown on.
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1997; Sugiura and Berditchevski, 1999), and it has been
proposed that they exert their function by promoting as-
sembly of signaling complexes. TM4SF proteins associate
with other TM4SF members, for example, CD4, CD8,
PETA-3, NAG-2, and CR2/CD19 (Imai and Yoshie, 1993;
Tachibana et al., 1997; Yanez-Mo et al., 1998), and with in-
tegrins (Berditchevski et al., 1996; Hadjiargyrou et al.,
1996; Maecker et al., 1997; Yanez-Mo et al., 1998; Yauch et
al., 1998). The discovery that OSP/claudin-11 associated
with a member of the TM4SF led us to investigate whether
OAP-1 and OSP/claudin-11 formed a complex that in-
cludes integrins. Oligodendrocyte precursors in vitro ex-
press the integrins a6b1, avb1, and avb3 subunits (Milner
and Ffrench-Constant, 1994; Shaw et al., 1996). Because
many tetraspanins interact with b1 integrin subunits, we
tested the presence and association of b1 integrin subunit
with OSP/claudin-11 and OAP-1. The association of these
three proteins was first suggested by coimmunoprecipita-
tion in mouse brain homogenates and in primary oligoden-
drocytes homogenates under relatively stringent condi-
tions. Double immunocytochemistry showed colocalization
of OSP/claudin-11, OAP-1, and b1 integrin in the cell body
and processes of most oligodendrocytes. Surface biotinyla-
tion and immunoelectron microscopy demonstrated the
presence of OSP/claudin-11 and OAP-1 on the oligoden-
drocyte membrane surface, but it is still not clear whether
OSP/claudin-11 complexes with OAP-1 and b1 integrin at
TJs. This would not be unprecedented, since some mem-
bers of the TM4SF have been found at cell-to-cell contacts
where they are also associated with integrins. For example,
Figure 7. Overexpression of OSP/claudin-11 and OAP-1 in-
creases proliferation in CIMO cells. (A) Northern blot of CIMO
cells grown at 378C (lanes 1 and 3) and 338C (lanes 2 and 4)
probed with a 32P-labeled 2-kb cDNA of OSP/claudin-11 (lanes 1
and 2) and 1.9-kB cDNA of OAP-1 (lanes 3 and 4). Both OSP/
claudin-11 and OAP-1 expression is increased at 338C during
proliferation. (B) Western blot of CIMO cells transfected with
control vector (lanes 1 and 3) and OSP (lanes 2 and 4) probed
with anti-OSP antibody at 338C (lanes 1 and 2) and 378C (lanes 3
and 4). (Bottom panel) Western blot of CIMO cells transfected
with OAP-1 (lane 1) and control vector (lane 2) at 378C probed
with anti–OAP-1 antibody confirms increased expression in
these stable transfectents. (C) [3H]Thymidine incorporation into
DNA of CIMO cells transfected with control vectors (pBabe and
pcDNA) and OSP/claudin-11, antisense OSP/claudin-11, PLP,
MBP, and OAP-1 constructs were observed under nonpermissive
(378C, minus Ig) and permissive conditions (338C, plus Ig). OSP/
claudin-11–transfected cells had a significant effect on proliferation
at 338C, whereas OAP-1 had a more generalized effect at both 338C
and 378C. Control CIMO cells incorporated 4,000 6 800 cpm/well/
12 h, similar to the control vector transfected CIMO cells (aver-
age 6 SEM, n 5 24–32; 500 cells/well, each well counted in tripli-
cates). OSP/claudin-11 versus pBabe vector at 378C (***P ,
0.0005), and OAP-1 versus pcDNA vector at 338C and 378C (**P ,
0.005) (Student’s t test).
Figure 8. Oligodendrocyte migration in the presence of OSP/
claudin-11, OAP-1, and b1 integrin antibodies and in OSP/
claudin-11–deficient cells. (A) Cells were migrated out of agarose
drops in medium: 2control, minus fibronectin; 1control, plus
fibronectin; anti–b1 integrin antibody; anti–OSP/claudin-11 anti-
body; anti–OAP-1 antibody; boiled inactive anti–OAP-1 antibody,
I anti–OAP-1; anti-GFAP antibody; GRGDSP peptide; and
GRGESP peptide. Except for the 2control, all other conditions
contained fibronectin. The total number of cells migrating out of
the agar drop was counted after 4 d. Statistical values represent
each condition versus positive control: **P , 0.0005; *P , 0.005
(Student’s t test). (B) Migration assays were performed using
oligodendrocytes isolated from wild-type (1/1), heterozygous
OSP (1/2), and homozygous knockout OSP (2/2) mice, and
cells were allowed to migrate in the presence (black bars) and
absence (stippled bars) of fibronectin. There was marked attenu-
ation of fibronectin-dependent migration in OSP/claudin-11–
deficient cells. Values are expressed as percentage of wild-type.
Heterozygous (1/2) versus wild-type (*P , 0.05) and homozygous
recessive (2/2) versus wild-type (**P , 0.005) (Student’s t test).
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the TM4SFs CD151/PETA-3, CD9, and CD81/TAPA-1
are all localized at intercellular contact sites of endothelial
cells (Sincock et al., 1997; Yanez-Mo et al., 1998). Experi-
ments involving the localization of OSP/claudin-11, OAP-1,
and b1 protein complex in TJs are presently ongoing.
It has been suggested that members of TM4SF and inte-
grins play a role in proliferation, migration, signal trans-
duction, cell activation, and tumor invasion (Hemler et al.,
1996; Maecker et al., 1997; Sugiura and Berditchevski,
1999). There is some evidence that at least integrins are in-
volved in some of these processes in oligodendrocytes
(Malek-Hedayat and Rome, 1994; Frost et al., 1999; Blas-
chuk et al., 2000). Data presented here suggest that the
OAP-1, OSP/claudin-11, and b1 integrin complex is in-
volved in regulating proliferation and migration of oligo-
dendrocytes. Overexpression of both OSP/claudin-11 and
OAP-1 resulted in increased growth in CIMO cells. This
finding is consistent with the previously described growth
regulatory effects of other TJ-associated proteins (Li and
Mrsny, 2000; Ryeom et al., 2000) and the elevated levels of
OSP/claudin-11 found in some tumors (Buznikov, A.G.,
and J.M. Bronstein, unpublished results).
Several lines of evidence support an integral role of inte-
grins and tetraspanins in cellular migration. Integrins have
been shown to regulate the migration of a range of neural
cells, including neural crest cells (Bronner-Fraser, 1993),
Schwann cells (Milner et al., 1997), oligodendrocyte pre-
cursor (Milner et al., 1996), and neuronal precursors
within the optic tectum (Galileo et al., 1992). The disrup-
tion of the b1 subunit gene by homologous recombination
has demonstrated the critical role of b1 integrins in migra-
tion (Fassler et al., 1995; Hirsch et al., 1996). Antibodies to
TM4SF members CD9, CD53, CD81, CD82, CD151/
PETA-3, and CD81/TAPA-1 alter integrin-mediated cell
migration (Domanico et al., 1997; Lagaudriere-Gesbert et
al., 1997; Yanez-Mo et al., 1998). Notably, in Schwann cells
of the peripheral nervous system, CD9 associates with in-
tegrins on the cell surface and an anti-CD9 monoclonal
antibody promoted adhesion and proliferation of Schwann
cells in vitro (Hadjiargyrou et al., 1996). Given this litera-
ture, it was not surprising that antibodies that bind to b1
integrin and OAP-1 proteins caused a profound decrease
of oligodendrocyte migration (Fig. 7 A). We did not ex-
pect the observed decrease in migration in the presence of
anti–OSP/claudin-11 antibody, which was targeted to a pu-
tative intracellular COOH termini epitope. To ensure that
we were seeing specific binding of this antibody, we per-
formed peptide-blocking experiments proving that the an-
tibody was recognizing this sequence. It is possible that it
is also recognizing another epitope, but this is highly un-
likely since immunohistochemical staining using this anti-
body is specific and almost identical with that described by
Morita et al. (1999) and staining is absent in OSP-null
cells. The specificity of the inhibitory response is sup-
ported by the fact that an unrelated antibody or inacti-
vated antibody had no effect on migration. Thus, the pre-
dicted structure of OSP/claudin-11 is wrong or is dynamic
or the antibody is gaining access to an intracellular
epitope. Given the potential importance of our finding
that anti–OSP/claudin-11 antibodies inhibit migration and
the unexpected staining of live cells, we felt it was essential
to confirm OSP/claudin-11’s role in migration using an-
other technique. The alterations in migratory behavior of
oligodendrocytes in the OSP-null mouse and the dose
dependency of this effect add strong support for our con-
clusion. It is possible that these results reflected altered
proliferation rates, but we feel this is unlikely. Oligoden-
drocyte cell cultures from transgenic animals appeared
similar to wild-type cultures, and myelin appears normal in
the adult OSP/claudin-11 knockout mouse (Gow et al.,
1999). Although quantitation of the number of oligoden-
drocytes has not been performed in these mice, it is possi-
ble that OSP/OAP-1/integrin–mediated migration is not
required for relatively normal myelination to occur during
development. Experiments are underway evaluating OSP/
claudin-11’s role in proliferation and migration during re-
myelination after injury.
The formation of TJs is normally associated with a cellu-
lar quiescent nonproliferating and nonmigratory state.
Conversely, integrin/TM4SF activation has been positively
associated with cell growth and migration, suggesting that
the interaction of OSP/claudin-11 with this complex may
therefore be a dynamic one. These associations could also
be important in cytoskeletal interactions and interactions
with different regulatory proteins. Further studies are nec-
essary to determine the importance of OSP/claudin-11/
OAP-1/integrin association in oligodendroglial prolifera-
tion and migration during myelin formation, maintenance,
and repair and to determine if this mechanism can be gen-
eralized to other members of the claudin family.
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